Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 8 of 8

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Reduction in treatment burden and edema in patients with diabetic macula edema following 0.2mg/day fluocinolone acetonide implant.

Clinton Ellingson; John William Kitchens; Thomas W Stone

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4813.

ARVO Annual Meeting Abstract June 2015

Systematic Review of Safety Across the Phase 2 and 3 Clinical Trials of Intravitreal Aflibercept Injection in Neovascular Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, and Diabetic Macular Edema

John William Kitchens

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4606.

ARVO Annual Meeting Abstract April 2014

Intravitreal Aflibercept for the treatment of Choroidal Neovascularization (CNV) secondary to Presumed Ocular Histoplasmosis Syndrome (POHS): Short-term Results From the HANDLE Study

Brian Toussaint; Dennis M Marcus; Daniel Miller; John W Kitchens; Harinderjit Singh; Robert Foster; Michael R Petersen; Robert Sisk; Christopher Riemann

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3923.

ARVO Annual Meeting Abstract March 2012

Visual Acuity and Injection Frequency Results of 2mg Ranibizumab for Pigment Epithelial Detachments Refractory to Conventional Dosing in the HiPED study

Anne E. Fung; Brandon G. Busbee; John W. Kitchens; Jan Kristine Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4180.

ARVO Annual Meeting Abstract March 2012

Fluorescein Angiographic Response to 2mg Ranibizumab for AMD Pigment Epithelial Detachments Refractory to Conventional Dosing in the HiPED Study

Edward H. Wood; John W. Kitchens; Anne E. Fung; Brandon G. Busbee; Jan K. Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2040.

ARVO Annual Meeting Abstract March 2012

OCT response to 2mg ranibizumab for AMD Pigment Epithelial Detachments refractory to conventional dosing in the HiPED study

Brandon G. Busbee; Anne E. Fung; John W. Kitchens; Brandon J. Lujan; Jan Kristine Bayabo; Richard E. Shaw

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2041.

ARVO Annual Meeting Abstract March 2012

Volumetric SDOCT Imaging of Pigment Epithelial Detachments in the HiPED Study

Jan Kristine T. Bayabo; Anne E. Fung; John W. Kitchens; Brandon G. Busbee; Brandon J. Lujan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):818.

ARVO Annual Meeting Abstract April 2011

A Pilot Study of Pharmacogenetics as a Predictor of Outcome in Patients Receiving Intravitreal Anti-VEGF Therapy in Age Related Macular Degeneration (AMD)

John W. Kitchens; Nawal Kassem; William Wood; Thomas Stone; Rick Isernhagen; Brad Hancock; Lang Li; Joshua Waymire; Bryan Schneider

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5259.

Advertisement